版本:
中国

BRIEF-Ocular Therapeutix Q4 loss per share $0.52

March 10 Ocular Therapeutix Inc:

* Ocular Therapeutix(tm) reports fourth quarter and full year 2016 financial results

* Q4 loss per share $0.52

* Q4 earnings per share view $-0.45 -- Thomson Reuters I/B/E/S

* Qtrly total revenue $511,000 versus $436,000

* Ocular Therapeutix Inc - as of december 31, 2016, cash, cash equivalents and marketable securities totaled $68.1 million

* Will need to obtain additional capital to support planned commercial launch of dextenza, subject to fda approval Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐